<DOC>
	<DOC>NCT00281034</DOC>
	<brief_summary>1. To survey the health-related quality of life using the SF-36v2 score of patients with chronic brain infarction in Japan 2. Chronic brain infarction in Japan is better than EU/USA</brief_summary>
	<brief_title>OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)</brief_title>
	<detailed_description>Period:2005-2007 Observation Time:baseline, 8week, 24week matters investigated: 1. QOL determination using SF-36 v2 2. Age, sex, brain infarction type, stroke severity (modified Rankin scale), side of stroke, complication, smoking, alcohol, dizziness-vertigo-presyncope-light headedness, combination medicine, subjective symptoms, psychic symptoms, rehabilitation, recurrence, evaluation of depression (Japan-Stroke Scale (JSS)-D)</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>1. Patients whose last attack occurred more than 1 month ago 2. Outpatients (including hospitalization for rehabilitation) 3. Japanese nationality 4. Patients who consented to participate in this study 5. Group I: Patients with dizziness, vertigo, presyncope, and lightheadedness which are likely due to secondary chronic cerebral circulation impairment associated with sequelae of brain infarction, and patients for whom KETAS (IBUDILAST) was prescribed Group II: Patients without dizziness, vertigo, presyncope, and lightheadedness which are likely due to chronic cerebral circulation impairment associated with sequelae of brain infarction 1. Patients who cannot read, understand and fill in the questionnaire by themselves 2. Patients who idle their time away 3. Patients who are hospitalized 4. Patients who are undergoing treatment for dizziness, vertigo, presyncope, lightheadedness which are likely due to chronic cerebral circulation impairment associated with sequelae of brain infarction 5. Patients whose dizziness, vertigo, presyncope, and lightheadedness is definitely or likely caused by Meniere disease, vestibular neuronitis, benign paroxysmal positional vertigo, otitis media, or epilepsy6. Patients whom the investigator judges are not suitable to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>brain infarction</keyword>
	<keyword>SF-36</keyword>
	<keyword>HRQOL</keyword>
	<keyword>Japan</keyword>
	<keyword>Post-stroke syndrome</keyword>
</DOC>